日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2026/05/08 | 4,314 | 4,315 | 4,093 | 4,093 | -700 | -14.6% | 729,400 |
| 2026/05/07 | 4,800 | 4,848 | 4,739 | 4,793 | +13 | +0.3% | 204,200 |
| 2026/05/01 | 4,768 | 4,780 | 4,659 | 4,780 | -10 | -0.2% | 188,000 |
| 2026/04/30 | 4,887 | 4,910 | 4,762 | 4,790 | -99 | -2% | 191,900 |
| 2026/04/28 | 4,878 | 4,889 | 4,817 | 4,889 | +53 | +1.1% | 132,700 |
| 2026/04/27 | 4,867 | 4,885 | 4,817 | 4,836 | -75 | -1.5% | 184,200 |
| 2026/04/24 | 4,990 | 5,021 | 4,877 | 4,911 | -113 | -2.2% | 215,600 |
| 2026/04/23 | 4,960 | 5,071 | 4,960 | 5,024 | +3 | +0.1% | 175,800 |
| 2026/04/22 | 5,012 | 5,045 | 4,972 | 5,021 | +29 | +0.6% | 170,000 |
| 2026/04/21 | 5,090 | 5,102 | 4,955 | 4,992 | -113 | -2.2% | 297,800 |
| 2026/04/20 | 5,147 | 5,190 | 5,078 | 5,105 | +13 | +0.3% | 159,000 |
| 2026/04/17 | 5,104 | 5,131 | 5,082 | 5,092 | -49 | -1% | 191,700 |
| 2026/04/16 | 5,192 | 5,211 | 5,100 | 5,141 | -19 | -0.4% | 142,700 |
| 2026/04/15 | 5,189 | 5,239 | 5,148 | 5,160 | +24 | +0.5% | 127,700 |
| 2026/04/14 | 5,149 | 5,171 | 5,100 | 5,136 | +35 | +0.7% | 203,500 |
| 2026/04/13 | 5,110 | 5,129 | 5,076 | 5,101 | -51 | -1% | 190,400 |
| 2026/04/10 | 5,200 | 5,297 | 5,129 | 5,152 | -91 | -1.7% | 189,700 |
| 2026/04/09 | 5,323 | 5,334 | 5,243 | 5,243 | -51 | -1% | 113,900 |
| 2026/04/08 | 5,414 | 5,420 | 5,292 | 5,294 | -20 | -0.4% | 188,300 |
| 2026/04/07 | 5,296 | 5,345 | 5,261 | 5,314 | +18 | +0.3% | 180,600 |
| 2026/04/06 | 5,335 | 5,340 | 5,273 | 5,296 | -15 | -0.3% | 90,600 |
| 2026/04/03 | 5,273 | 5,318 | 5,225 | 5,311 | +16 | +0.3% | 171,100 |
| 2026/04/02 | 5,397 | 5,406 | 5,285 | 5,295 | -86 | -1.6% | 221,700 |
| 2026/04/01 | 5,250 | 5,381 | 5,212 | 5,381 | +268 | +5.2% | 223,300 |
| 2026/03/31 | 5,165 | 5,229 | 5,113 | 5,113 | -52 | -1% | 216,000 |
| 2026/03/30 | 5,098 | 5,263 | 5,066 | 5,165 | -202 | -3.8% | 379,100 |
| 2026/03/27 | 5,312 | 5,367 | 5,280 | 5,367 | +75 | +1.4% | 357,000 |
| 2026/03/26 | 5,262 | 5,346 | 5,258 | 5,292 | +62 | +1.2% | 276,500 |
| 2026/03/25 | 5,227 | 5,274 | 5,225 | 5,230 | +69 | +1.3% | 282,600 |
| 2026/03/24 | 5,161 | 5,230 | 5,070 | 5,161 | +235 | +4.8% | 431,500 |
| 2026/03/23 | 5,045 | 5,121 | 4,926 | 4,926 | -87 | -1.7% | 493,300 |
| 2026/03/19 | 5,090 | 5,139 | 5,012 | 5,013 | -208 | -4% | 509,500 |
| 2026/03/18 | 5,205 | 5,226 | 5,160 | 5,221 | -21 | -0.4% | 263,900 |
| 2026/03/17 | 5,232 | 5,306 | 5,184 | 5,242 | +7 | +0.1% | 239,000 |
| 2026/03/16 | 5,460 | 5,467 | 5,175 | 5,235 | -237 | -4.3% | 377,900 |
| 2026/03/13 | 5,344 | 5,499 | 5,329 | 5,472 | +60 | +1.1% | 391,300 |
| 2026/03/12 | 5,601 | 5,601 | 5,335 | 5,412 | -198 | -3.5% | 472,400 |
| 2026/03/11 | 5,451 | 5,626 | 5,404 | 5,610 | +320 | +6% | 749,300 |
| 2026/03/10 | 5,127 | 5,290 | 5,066 | 5,290 | +163 | +3.2% | 375,700 |
| 2026/03/09 | 4,834 | 5,148 | 4,825 | 5,127 | +223 | +4.5% | 626,500 |
| 2026/03/06 | 4,834 | 4,904 | 4,781 | 4,904 | ±0 | ±0% | 207,800 |
| 2026/03/05 | 4,905 | 4,965 | 4,887 | 4,904 | +69 | +1.4% | 229,400 |
| 2026/03/04 | 4,912 | 4,925 | 4,747 | 4,835 | -165 | -3.3% | 419,900 |
| 2026/03/03 | 5,076 | 5,125 | 5,000 | 5,000 | -127 | -2.5% | 330,600 |
| 2026/03/02 | 5,158 | 5,207 | 5,100 | 5,127 | -17 | -0.3% | 293,300 |
| 2026/02/27 | 5,096 | 5,166 | 5,081 | 5,144 | +48 | +0.9% | 264,900 |
| 2026/02/26 | 5,081 | 5,104 | 5,034 | 5,096 | +81 | +1.6% | 257,300 |
| 2026/02/25 | 5,029 | 5,065 | 4,955 | 5,015 | +19 | +0.4% | 240,600 |
| 2026/02/24 | 4,960 | 5,033 | 4,857 | 4,996 | -19 | -0.4% | 330,200 |
| 2026/02/20 | 5,075 | 5,075 | 5,005 | 5,015 | -48 | -0.9% | 263,300 |
1～
50
件表示中 / 3937件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 409,300円 | +6.1% | -6.7% | 3.03% | 10.49倍 | 1.06倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 参天薬 | 161,750円 | -2.0% | -7.3% | 2.35% | 15.30倍 | 1.89倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| 久光薬 | 604,000円 | - | - | - | - | 1.46倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。ＭＢＯで上場廃止へ |
| ツムラ | 358,200円 | +9.3% | -18.7% | 4.02% | 10.99倍 | 0.91倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サワイＧＨＤ | 210,200円 | +7.1% | +526.4% | 2.62% | 17.34倍 | 1.37倍 |
|
後発医薬品大手で、幅広い取り扱い品目。２１年に沢井製薬が持株会社化。安定供給へ生産増強中 |
市場注目の銘柄
チャート関連のコラム
